Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

“Stigma is where the harm comes from”: Exploring expectations and lived experiences of hepatitis C virus post-treatment trajectories among people who inject drugs
Trevor Goodyear, Helen Brown, Annette J. Browne, et al.
International Journal of Drug Policy (2021) Vol. 96, pp. 103238-103238
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

“I would never go to the doctor and speak about steroids”: Anabolic androgenic steroids, stigma and harm
Luke Cox, Timothy Piatkowski, Jim McVeigh
Drugs Education Prevention and Policy (2024), pp. 1-13
Open Access | Times Cited: 15
‘The general concept is a safer use approach’: how image and performance enhancing drug coaches negotiate safety through community care
Timothy Piatkowski, Luke Cox, Nick Gibbs, et al.
Drugs Education Prevention and Policy (2024), pp. 1-9
Closed Access | Times Cited: 13
How do relational practices co-constitute care for people who use drugs? The social and political dimensions of peer-led harm reduction
Timothy Piatkowski, Kate Seear, Steph Reeve, et al.
International Journal of Drug Policy (2024) Vol. 133, pp. 104614-104614
Open Access | Times Cited: 8
Community pharmacy’s role in dispensing androgens and supporting harm reduction amid current policy dilemmas
Timothy Piatkowski, Lkhagvadulam Ayurzana, Michelle A. King, et al.
Substance Abuse Treatment Prevention and Policy (2025) Vol. 20, Iss. 1
Open Access
Expanding access to healthcare for people who use drugs and sex workers: hepatitis C elimination implications from a qualitative study of healthcare experiences in British Columbia, Canada
Nance Cunningham, Jessica Lamb, Amanda Staller, et al.
Harm Reduction Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 3
Factors associated with experiencing stigma, discrimination, and negative health care treatment among people who inject drugs
Timothy R. Broady, Heather Valerio, Maryam Alavi, et al.
International Journal of Drug Policy (2024) Vol. 128, pp. 104468-104468
Open Access | Times Cited: 3
“In Sweden you are worthless. In Denmark you get an identity again” – on being perceived and received as a person who uses drugs in different drug policy settings
Julie Holeksa
Harm Reduction Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 3
Public reimbursement policies in Canada for direct-acting antiviral treatment of hepatitis C virus infection: A descriptive study
Gaelen Snell, Alison D. Marshall, Jennifer Van Gennip, et al.
Canadian Liver Journal (2023) Vol. 6, Iss. 2, pp. 190-200
Open Access | Times Cited: 9
‘I’m not hep C free’: afterlives of hepatitis C in the era of cure
Dion Kagan, Kate Seear, Emily Lenton, et al.
Medical Humanities (2023) Vol. 49, Iss. 4, pp. 678-687
Closed Access | Times Cited: 8
The time of cure: hepatitis C treatment and the matter of reinfection among people who inject drugs
Jake Rance, Jason Grebely, Carla Treloar
Health Sociology Review (2024) Vol. 33, Iss. 1, pp. 104-118
Open Access | Times Cited: 2
Troubling complaint: Addressing hepatitis C‐related stigma and discrimination through complaint mechanisms
Emily Lenton, Dion Kagan, Kate Seear, et al.
Sociology of Health & Illness (2024) Vol. 46, Iss. 7, pp. 1400-1418
Open Access | Times Cited: 2
Stigma in steatotic liver disease: A survey of patients from Saudi Arabia
Saleh A. Alqahtani, Khalid Alswat, Mohamed Mawardi, et al.
Saudi Journal of Gastroenterology (2024) Vol. 30, Iss. 5, pp. 335-341
Open Access | Times Cited: 2
Understanding the Process of Drug Addiction Recovery Through First-Hand Experiences: A Qualitative Study in the Netherlands Using Lifeline Interviews
Thomas F. Martinelli, Diana Roeg, Lore Bellaert, et al.
Qualitative Health Research (2023) Vol. 33, Iss. 10, pp. 857-870
Open Access | Times Cited: 6
Shame and stigma in association with the HCV cascade to cure among people who inject drugs
Abigail Batchelder, Moonseong Heo, Jacklyn D. Foley, et al.
Drug and Alcohol Dependence (2023) Vol. 253, pp. 111013-111013
Closed Access | Times Cited: 6
Patient-Reported Outcomes During and After Hepatitis C Virus Direct-Acting Antiviral Treatment Among People Who Inject Drugs
Qinglu Cheng, Evan B. Cunningham, Sophy Shih, et al.
Value in Health (2023) Vol. 26, Iss. 6, pp. 883-892
Open Access | Times Cited: 5
Changes in Health-related Quality of Life for Hepatitis C Virus–Infected People Who Inject Drugs While on Opioid Agonist Treatment Following Sustained Virologic Response
Mirinda Ann Gormley, Matthew J. Akiyama, Lior Rennert, et al.
Clinical Infectious Diseases (2021) Vol. 74, Iss. 9, pp. 1586-1593
Open Access | Times Cited: 11
Addressing injecting related risks among people who inject both opioids and stimulants: Findings from an Australian survey of people who inject drugs
Loren Brener, Theresa Caruana, Timothy R. Broady, et al.
Addictive Behaviors Reports (2021) Vol. 15, pp. 100398-100398
Open Access | Times Cited: 11
Reducing stigma impacting children and adolescents in low- and middle-income countries: The development of a common multi-component stigma reduction intervention
Kim Hartog, Ruth M. H. Peters, Racheal Kisakye Tukahiirwa, et al.
PLoS ONE (2023) Vol. 18, Iss. 10, pp. e0292064-e0292064
Open Access | Times Cited: 4
An evolutionary concept analysis: stigma among women living with hepatitis C
Chelsea Masterman, Andrew B. Mendlowitz, Camelia Capraru, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Progress and remaining challenges to address hepatitis C, other infectious diseases, and drug-related harms to improve the health of people who use drugs
Jason Grebely, Alexandra B. Collins, Andreea Adelina Artenie, et al.
International Journal of Drug Policy (2021) Vol. 96, pp. 103469-103469
Closed Access | Times Cited: 9
Accessing hepatitis C direct acting antivirals among people living with hepatitis C: a qualitative study
Tony Antoniou, Cheryl Pritlove, Dana Shearer, et al.
International Journal for Equity in Health (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Echoes and Antibodies: Legal Veridiction and the Emergence of the Perpetual Hepatitis C Subject
Kate Seear, Suzanne Fraser, Sean Mulcahy, et al.
Social & Legal Studies (2022) Vol. 32, Iss. 2, pp. 216-236
Open Access | Times Cited: 5
Post-crisis imaginaries in the time of direct-acting antiviral hepatitis C treatment
Renae Fomiatti, Adrian Farrugia, Suzanne Fraser, et al.
Time & Society (2022) Vol. 32, Iss. 1, pp. 50-74
Open Access | Times Cited: 5
The impact of disease-related knowledge on perceptions of stigma among patients with Hepatitis C Virus (HCV) infection
M. Elle Saine, Julia E. Szymczak, Tyler M. Moore, et al.
PLoS ONE (2021) Vol. 16, Iss. 10, pp. e0258143-e0258143
Open Access | Times Cited: 7
Pre-Empting Stigma and Complicating Trauma: Narratives of Gay and Bisexual Men who Inject Drugs in Australia
Sophia Schroeder, Carla Treloar, Adam Bourne, et al.
Qualitative Health Research (2023) Vol. 33, Iss. 8-9, pp. 688-700
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top